New peer-reviewed study finds hydroxychloroquine’s life-saving benefits.
===============
The results of a large-scale analysis, conducted by the prestigious Henry Ford Health System, was published last week in the peer-reviewed International Journal of Infectious Diseases.
The study examined 2,541 patients who had been hospitalized in six Henry Ford hospitals between March 10 and May 2, 2020.
More than 90% of the patients receiving hydroxychloroquine were treated with the drug within 48 hours of admission to the hospital.
The study’s fundamental finding:
26.4% of patients who did not receive hydroxychloroquine died.
But among those who received hydroxychloroquine, fewer than half that number — 13% — died.
The difference in mortality is, by all measures, statistically significant.
How can that be?
